T1	Participants 567 634	in T1DM patients on continuous subcutaneous insulin infusion (CSII)
T2	Participants 813 819	order.
T3	Participants 820 857	Twenty-eight patients were randomized
T4	Participants 888 914	and 23 completed the study
